FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Msci: Q1 Eps Beat As Msci's Operating Leverage On Full Display

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

MSCI posted strong Q1 2026 results with operating EPS of $4.55 vs. $4.00 in the prior year, beating consensus by $0.09, while revenues of $851M (+14% Y/Y) exceeded estimates by $10M. The company achieved two consecutive quarters of double-digit revenue growth after four quarters below 10%, with operating margins expanding 310 bps to 53.7% as expense growth was managed at 6.8%. The Index segment drove performance with $496M in revenues (+18% Y/Y) and strong asset-based fee growth of $225M (+27% Y/Y), supported by robust $103B in quarterly cash inflows. AUM in ETFs linked to MSCI equity indexes reached $2.403T at quarter-end, though basis point fees declined 6 bps Q/Q to a new low of 2.35. Retention rates recovered to the highest level since 2023 at 95.4% after falling to 92.8% in early 2024, with Index leading at 96.9% and Analytics maintaining 95.3%, while net new recurring subscription sales surged 51.7% Y/Y, indicating healthy demand momentum.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605